List of Tables
Table 1. Global Knee-high Anti-Embolism Socks Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Knee-high Anti-Embolism Socks Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Knee-high Anti-Embolism Socks Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Knee-high Anti-Embolism Socks Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Knee-high Anti-Embolism Socks Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Knee-high Anti-Embolism Socks Sales by Region (2020-2025) & (K Units)
Table 8. Global Knee-high Anti-Embolism Socks Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Knee-high Anti-Embolism Socks Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Knee-high Anti-Embolism Socks Sales Share by Manufacturers (2020-2025)
Table 12. Global Knee-high Anti-Embolism Socks Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Knee-high Anti-Embolism Socks Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Knee-high Anti-Embolism Socks by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee-high Anti-Embolism Socks as of 2024)
Table 16. Global Knee-high Anti-Embolism Socks Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Knee-high Anti-Embolism Socks Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Knee-high Anti-Embolism Socks Manufacturing Base and Headquarters
Table 19. Global Knee-high Anti-Embolism Socks Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Knee-high Anti-Embolism Socks Sales by Type (2020-2025) & (K Units)
Table 23. Global Knee-high Anti-Embolism Socks Sales by Type (2026-2031) & (K Units)
Table 24. Global Knee-high Anti-Embolism Socks Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Knee-high Anti-Embolism Socks Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Knee-high Anti-Embolism Socks ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Knee-high Anti-Embolism Socks Sales by Application (2020-2025) & (K Units)
Table 29. Global Knee-high Anti-Embolism Socks Sales by Application (2026-2031) & (K Units)
Table 30. Knee-high Anti-Embolism Socks High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Knee-high Anti-Embolism Socks Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Knee-high Anti-Embolism Socks Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Knee-high Anti-Embolism Socks ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Knee-high Anti-Embolism Socks Growth Accelerators and Market Barriers
Table 37. North America Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Knee-high Anti-Embolism Socks Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Knee-high Anti-Embolism Socks Growth Accelerators and Market Barriers
Table 40. Europe Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Knee-high Anti-Embolism Socks Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Knee-high Anti-Embolism Socks Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Knee-high Anti-Embolism Socks Growth Accelerators and Market Barriers
Table 45. Southeast Asia Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Knee-high Anti-Embolism Socks Investment Opportunities and Key Challenges
Table 47. Central and South America Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Knee-high Anti-Embolism Socks Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Knee-high Anti-Embolism Socks Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Varitek Corporation Information
Table 51. Varitek Description and Major Businesses
Table 52. Varitek Product Models, Descriptions and Specifications
Table 53. Varitek Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Varitek Sales Value Proportion by Product in 2024
Table 55. Varitek Sales Value Proportion by Application in 2024
Table 56. Varitek Sales Value Proportion by Geographic Area in 2024
Table 57. Varitek Knee-high Anti-Embolism Socks SWOT Analysis
Table 58. Varitek Recent Developments
Table 59. Medtronic(Covidien) Corporation Information
Table 60. Medtronic(Covidien) Description and Major Businesses
Table 61. Medtronic(Covidien) Product Models, Descriptions and Specifications
Table 62. Medtronic(Covidien) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic(Covidien) Sales Value Proportion by Product in 2024
Table 64. Medtronic(Covidien) Sales Value Proportion by Application in 2024
Table 65. Medtronic(Covidien) Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic(Covidien) Knee-high Anti-Embolism Socks SWOT Analysis
Table 67. Medtronic(Covidien) Recent Developments
Table 68. Sigvaris Corporation Information
Table 69. Sigvaris Description and Major Businesses
Table 70. Sigvaris Product Models, Descriptions and Specifications
Table 71. Sigvaris Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Sigvaris Sales Value Proportion by Product in 2024
Table 73. Sigvaris Sales Value Proportion by Application in 2024
Table 74. Sigvaris Sales Value Proportion by Geographic Area in 2024
Table 75. Sigvaris Knee-high Anti-Embolism Socks SWOT Analysis
Table 76. Sigvaris Recent Developments
Table 77. Medi Corporation Information
Table 78. Medi Description and Major Businesses
Table 79. Medi Product Models, Descriptions and Specifications
Table 80. Medi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Medi Sales Value Proportion by Product in 2024
Table 82. Medi Sales Value Proportion by Application in 2024
Table 83. Medi Sales Value Proportion by Geographic Area in 2024
Table 84. Medi Knee-high Anti-Embolism Socks SWOT Analysis
Table 85. Medi Recent Developments
Table 86. BSN Medical Corporation Information
Table 87. BSN Medical Description and Major Businesses
Table 88. BSN Medical Product Models, Descriptions and Specifications
Table 89. BSN Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BSN Medical Sales Value Proportion by Product in 2024
Table 91. BSN Medical Sales Value Proportion by Application in 2024
Table 92. BSN Medical Sales Value Proportion by Geographic Area in 2024
Table 93. BSN Medical Knee-high Anti-Embolism Socks SWOT Analysis
Table 94. BSN Medical Recent Developments
Table 95. Juzo Corporation Information
Table 96. Juzo Description and Major Businesses
Table 97. Juzo Product Models, Descriptions and Specifications
Table 98. Juzo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Juzo Recent Developments
Table 100. 3M Corporation Information
Table 101. 3M Description and Major Businesses
Table 102. 3M Product Models, Descriptions and Specifications
Table 103. 3M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. 3M Recent Developments
Table 105. Bauerfeind AG Corporation Information
Table 106. Bauerfeind AG Description and Major Businesses
Table 107. Bauerfeind AG Product Models, Descriptions and Specifications
Table 108. Bauerfeind AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Bauerfeind AG Recent Developments
Table 110. Thuasne Corporate Corporation Information
Table 111. Thuasne Corporate Description and Major Businesses
Table 112. Thuasne Corporate Product Models, Descriptions and Specifications
Table 113. Thuasne Corporate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Thuasne Corporate Recent Developments
Table 115. Pretty Legs Hosiery Corporation Information
Table 116. Pretty Legs Hosiery Description and Major Businesses
Table 117. Pretty Legs Hosiery Product Models, Descriptions and Specifications
Table 118. Pretty Legs Hosiery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Pretty Legs Hosiery Recent Developments
Table 120. Salzmann-Group Corporation Information
Table 121. Salzmann-Group Description and Major Businesses
Table 122. Salzmann-Group Product Models, Descriptions and Specifications
Table 123. Salzmann-Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Salzmann-Group Recent Developments
Table 125. Paul Hartmann Corporation Information
Table 126. Paul Hartmann Description and Major Businesses
Table 127. Paul Hartmann Product Models, Descriptions and Specifications
Table 128. Paul Hartmann Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Paul Hartmann Recent Developments
Table 130. Cizeta Medicali Corporation Information
Table 131. Cizeta Medicali Description and Major Businesses
Table 132. Cizeta Medicali Product Models, Descriptions and Specifications
Table 133. Cizeta Medicali Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Cizeta Medicali Recent Developments
Table 135. Belsana Medical Corporation Information
Table 136. Belsana Medical Description and Major Businesses
Table 137. Belsana Medical Product Models, Descriptions and Specifications
Table 138. Belsana Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Belsana Medical Recent Developments
Table 140. Gloria Med Corporation Information
Table 141. Gloria Med Description and Major Businesses
Table 142. Gloria Med Product Models, Descriptions and Specifications
Table 143. Gloria Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Gloria Med Recent Developments
Table 145. Zhende Medical Group Corporation Information
Table 146. Zhende Medical Group Description and Major Businesses
Table 147. Zhende Medical Group Product Models, Descriptions and Specifications
Table 148. Zhende Medical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Zhende Medical Group Recent Developments
Table 150. Maizi Corporation Information
Table 151. Maizi Description and Major Businesses
Table 152. Maizi Product Models, Descriptions and Specifications
Table 153. Maizi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Maizi Recent Developments
Table 155. TOKO Corporation Information
Table 156. TOKO Description and Major Businesses
Table 157. TOKO Product Models, Descriptions and Specifications
Table 158. TOKO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. TOKO Recent Developments
Table 160. Okamoto Corporation Corporation Information
Table 161. Okamoto Corporation Description and Major Businesses
Table 162. Okamoto Corporation Product Models, Descriptions and Specifications
Table 163. Okamoto Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Okamoto Corporation Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Knee-high Anti-Embolism Socks Product Picture
Figure 2. Global Knee-high Anti-Embolism Socks Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Open Toes Product Picture
Figure 4. Closed Toes Product Picture
Figure 5. Global Knee-high Anti-Embolism Socks Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Online Sales
Figure 7. Offline Sales
Figure 8. Knee-high Anti-Embolism Socks Report Years Considered
Figure 9. Global Knee-high Anti-Embolism Socks Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 11. Global Knee-high Anti-Embolism Socks Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Knee-high Anti-Embolism Socks Revenue Market Share by Region (2020-2031)
Figure 13. Global Knee-high Anti-Embolism Socks Sales (2020-2031) & (K Units)
Figure 14. Global Knee-high Anti-Embolism Socks Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Knee-high Anti-Embolism Socks Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Knee-high Anti-Embolism Socks Sales Volume Market Share in 2024
Figure 17. Global Knee-high Anti-Embolism Socks Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Open Toes Revenue Market Share by Manufacturer in 2024
Figure 20. Closed Toes Revenue Market Share by Manufacturer in 2024
Figure 21. Global Knee-high Anti-Embolism Socks Sales Market Share by Type (2020-2031)
Figure 22. Global Knee-high Anti-Embolism Socks Revenue Market Share by Type (2020-2031)
Figure 23. Global Knee-high Anti-Embolism Socks Sales Market Share by Application (2020-2031)
Figure 24. Global Knee-high Anti-Embolism Socks Revenue Market Share by Application (2020-2031)
Figure 25. North America Knee-high Anti-Embolism Socks Sales YoY (2020-2031) & (K Units)
Figure 26. North America Knee-high Anti-Embolism Socks Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) in 2024
Figure 28. North America Knee-high Anti-Embolism Socks Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Knee-high Anti-Embolism Socks Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Knee-high Anti-Embolism Socks Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Knee-high Anti-Embolism Socks Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) in 2024
Figure 38. Europe Knee-high Anti-Embolism Socks Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Knee-high Anti-Embolism Socks Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 43. France Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Knee-high Anti-Embolism Socks Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Knee-high Anti-Embolism Socks Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Knee-high Anti-Embolism Socks Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Knee-high Anti-Embolism Socks Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 58. India Knee-high Anti-Embolism Socks Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Knee-high Anti-Embolism Socks Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Knee-high Anti-Embolism Socks Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Knee-high Anti-Embolism Socks Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Knee-high Anti-Embolism Socks Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Knee-high Anti-Embolism Socks Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Knee-high Anti-Embolism Socks Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Knee-high Anti-Embolism Socks Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Knee-high Anti-Embolism Socks Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Knee-high Anti-Embolism Socks Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Knee-high Anti-Embolism Socks Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Knee-high Anti-Embolism Socks Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Knee-high Anti-Embolism Socks Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Knee-high Anti-Embolism Socks Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Knee-high Anti-Embolism Socks Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Knee-high Anti-Embolism Socks Revenue (2020-2025) & (US$ Million)
Figure 79. Knee-high Anti-Embolism Socks Industry Chain Mapping
Figure 80. Regional Knee-high Anti-Embolism Socks Manufacturing Base Distribution (%)
Figure 81. Global Knee-high Anti-Embolism Socks Production Market Share by Region (2020-2031)
Figure 82. Knee-high Anti-Embolism Socks Production Process
Figure 83. Regional Knee-high Anti-Embolism Socks Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
